Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer.


Journal

Brachytherapy
ISSN: 1873-1449
Titre abrégé: Brachytherapy
Pays: United States
ID NLM: 101137600

Informations de publication

Date de publication:
Historique:
received: 24 10 2019
revised: 02 01 2020
accepted: 02 01 2020
pubmed: 19 2 2020
medline: 29 12 2020
entrez: 19 2 2020
Statut: ppublish

Résumé

To examine the variability in prescribed dose due to contouring variations in intracavitary image-guided adaptive brachytherapy for cervical cancer. To identify correlations between dosimetric outcomes and delineation uncertainty metrics. A data set from an EMBRACE sub-study on contouring uncertainties was used, consisting of magnetic resonance images of six patients with cervical cancer delineated by 10 experienced observers (target volumes and organs at risk). Two gold standard contours were generated, an expert consensus and the simultaneous truth and performance level estimation. Plans were individually optimised to all of the contour sets (12 in total). Plans were applied to the gold standard contour sets, and dose volume histogram parameters including D There is a dosimetric variability between observers, patients and the gold standard contour used for analysis. Approximately 3 Gy D This study highlights the dosimetric differences interobserver uncertainty in contouring can have for cervical cancer brachytherapy. The importance of carefully choosing a gold standard from which to benchmark is reiterated.

Identifiants

pubmed: 32067884
pii: S1538-4721(20)30002-7
doi: 10.1016/j.brachy.2020.01.002
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-153

Informations de copyright

Copyright © 2020 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Lauren Bell (L)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia. Electronic address: lb998@uowmail.edu.au.

Lois Holloway (L)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia; Liverpool & Macarthur Cancer Therapy Centres, Liverpool, Australia; Ingham Institute for Applied Medical Research, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Institute of Medical Physics, University of Sydney, Sydney, Australia.

Kjersti Bruheim (K)

Department of Oncology, Oslo University Hospital, Oslo, Norway.

Primož Petrič (P)

Radiation Oncology Department, National Center for Cancer Care and Research, Doha, Qatar; Division of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia.

Christian Kirisits (C)

Department of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Vienna, Austria.

Kari Tanderup (K)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Richard Pötter (R)

Department of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Vienna, Austria.

Shalini Vinod (S)

Liverpool & Macarthur Cancer Therapy Centres, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia.

Karen Lim (K)

Liverpool & Macarthur Cancer Therapy Centres, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia.

Elise Pogson (E)

Liverpool & Macarthur Cancer Therapy Centres, Liverpool, Australia; Ingham Institute for Applied Medical Research, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia.

Peter Metcalfe (P)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia; Liverpool & Macarthur Cancer Therapy Centres, Liverpool, Australia; Ingham Institute for Applied Medical Research, Liverpool, Australia.

Taran Paulsen Hellebust (TP)

Department of Medical Physics, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH